{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ06914",
      "entity_text" : "hfNSCs",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "interpro:IPR001760",
      "entity_text" : "opsin",
      "entity_type" : "family"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The engineered chimeric opsin variant, which contained point mutated glutamic acid (E) to threonine (T) at 122 and 162 (C1V1 E122T / E162T; C1V1 ET-ET), was used to optically activate hfNSCs by light exposure at 539 nm XREF_BIBR.",
  "reading_complete" : "2020-08-02T16:02:15Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T16:00:16Z",
  "trigger" : "activate",
  "evidence" : [ "opsin variant, which contained point-mutated glutamic acid (E) to threonine (T) at 122 and 162 (C1V1 E122T/E162T; C1V1 ET-ET), was used to optically activate hfNSCs" ],
  "pmc_id" : "5695151",
  "score" : 0
}